These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Drug shortages--a critical challenge for the generic-drug market. Chabner BA N Engl J Med; 2011 Dec; 365(23):2147-9. PubMed ID: 22040167 [No Abstract] [Full Text] [Related]
13. Trying times for generic medicines in the USA. Lancet; 2013 Mar; 381(9872):1072. PubMed ID: 23540840 [No Abstract] [Full Text] [Related]
14. Sandoz sues FDA over delay in first biogeneric approval. Fox JL Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046 [No Abstract] [Full Text] [Related]
15. Patent infringement. Generic HIV drugmaker's patent claim is time-barred. AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916 [No Abstract] [Full Text] [Related]
16. Path to approval proves rocky for copycat biodrugs. Wadman M Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004 [No Abstract] [Full Text] [Related]
17. Pharmaceuticals and medical devices: cost savings. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
18. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557 [No Abstract] [Full Text] [Related]
19. Impossible? Outlawing state safety laws for generic drugs. Glantz LH; Annas GJ N Engl J Med; 2011 Aug; 365(8):681-3. PubMed ID: 21830958 [No Abstract] [Full Text] [Related]